Literature DB >> 21211737

The gut-brain axis: a major glucoregulatory player.

R Burcelin1.   

Abstract

Glucose homeostasis corresponds to the overall physiological, cellular, and molecular mechanisms which tightly maintain the glycaemia between ∼4.5 and ∼6 mM. The resulting blood glucose concentration is the consequence of a balance between the mechanisms that ensure the entry and the output of glucose in the blood. A dynamic balance needs hence to be perfectly achieved in order to maintain a physiological glycaemic concentration. Specialized cells from the intestine continuously detect changes in glucose concentration and send signals to peripheral tissues and the brain through the vagus nerve. The molecular mechanisms involved in glucose detection have not been perfectly defined but could resemble those from the insulin-secreting beta cells. The brain then integrates the enteric and circulating endocrine signals to generate a new signal towards peripheral tissues such as the pancreas, liver, muscles, and blood vessels. This metabolic reflex is called anticipatory since it allows the peripheral tissues to prepare for the adequate handling of nutrients. Diabetes is associated with an impaired anticipatory reflex, which hampers the proper detection of nutrients and leads to hyperglycaemic episodes. Recently, GLP-1-based therapies have demonstrated the improvement of glucose detection and their efficacy on glycaemic control. Although not yet fully demonstrated, GLP-1-based therapies regulate glucose sensors, which leads to the glycaemic improvement. Certainly other molecular targets could be identified to further generate new therapeutic strategies.
Copyright © 2010 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21211737     DOI: 10.1016/S1262-3636(10)70468-7

Source DB:  PubMed          Journal:  Diabetes Metab        ISSN: 1262-3636            Impact factor:   6.041


  16 in total

1.  Liraglutide targets the gut microbiota and the intestinal immune system to regulate insulin secretion.

Authors:  Julie Charpentier; Francois Briand; Benjamin Lelouvier; Florence Servant; Vincent Azalbert; Anthony Puel; Jeffrey E Christensen; Aurélie Waget; Maxime Branchereau; Céline Garret; Jérome Lluch; Christophe Heymes; Emmanuel Brousseau; Rémy Burcelin; Laurence Guzylack; Thierry Sulpice; Estelle Grasset
Journal:  Acta Diabetol       Date:  2021-03-15       Impact factor: 4.280

2.  Intestinotrophic glucagon-like peptide-2 (GLP-2) activates intestinal gene expression and growth factor-dependent pathways independent of the vasoactive intestinal peptide gene in mice.

Authors:  Bernardo Yusta; Dianne Holland; James A Waschek; Daniel J Drucker
Journal:  Endocrinology       Date:  2012-04-24       Impact factor: 4.736

Review 3.  The Role of the Vagal Nucleus Tractus Solitarius in the Therapeutic Effects of Obesity Surgery and Other Interventional Therapies on Type 2 Diabetes.

Authors:  Claudio Blasi
Journal:  Obes Surg       Date:  2016-12       Impact factor: 4.129

Review 4.  Glucose metabolism in fish: a review.

Authors:  Sergio Polakof; Stéphane Panserat; José L Soengas; Thomas W Moon
Journal:  J Comp Physiol B       Date:  2012-04-05       Impact factor: 2.200

Review 5.  Second generation antipsychotic-induced type 2 diabetes: a role for the muscarinic M3 receptor.

Authors:  Katrina Weston-Green; Xu-Feng Huang; Chao Deng
Journal:  CNS Drugs       Date:  2013-12       Impact factor: 5.749

6.  Consider the microbiome in the equation! They were here before us...and hosted us!

Authors:  José-Manuel Fernández-Real; Massimo Federici; Rémy Burcelin
Journal:  Rev Endocr Metab Disord       Date:  2019-12       Impact factor: 6.514

7.  Central GIP signaling stimulates peripheral GIP release and promotes insulin and pancreatic polypeptide secretion in nonhuman primates.

Authors:  Paul B Higgins; Robert E Shade; Irám P Rodríguez-Sánchez; Magdalena Garcia-Forey; M Elizabeth Tejero; V Saroja Voruganti; Shelley A Cole; Anthony G Comuzzie; Franco Folli
Journal:  Am J Physiol Endocrinol Metab       Date:  2016-08-16       Impact factor: 4.310

8.  GLP-1R activation for the treatment of stroke: updating and future perspectives.

Authors:  Vladimer Darsalia; David Nathanson; Thomas Nyström; Thomas Klein; Åke Sjöholm; Cesare Patrone
Journal:  Rev Endocr Metab Disord       Date:  2014-09       Impact factor: 6.514

9.  Identification of optimal reference genes for RT-qPCR in the rat hypothalamus and intestine for the study of obesity.

Authors:  B Li; E K Matter; H T Hoppert; B E Grayson; R J Seeley; D A Sandoval
Journal:  Int J Obes (Lond)       Date:  2013-05-24       Impact factor: 5.095

Review 10.  Regulation of glucose homeostasis by GLP-1.

Authors:  Prashant Nadkarni; Oleg G Chepurny; George G Holz
Journal:  Prog Mol Biol Transl Sci       Date:  2014       Impact factor: 3.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.